Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 56.2%

Neg 56.2% Neu 0% Pos 0%

Maxim Group analyst Anthony Vendetti maintains BioHarvest Sciences (NASDAQ:BHST) with a Buy and lowers the price target from $12 to $5.